S. Böhm, Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma, Clinical Cancer Research, vol.22, issue.12, pp.3025-3036, 2016.
DOI : 10.1158/1078-0432.CCR-15-2657

S. W. Criscione, Genome-wide characterization of human L1 antisense promoter-driven transcripts, BMC Genomics, vol.50, issue.1, p.463, 2016.
DOI : 10.1373/clinchem.2003.027102
URL : https://bmcgenomics.biomedcentral.com/track/pdf/10.1186/s12864-016-2800-5?site=bmcgenomics.biomedcentral.com

H. A. Cruickshanks and C. Tufarelli, Isolation of cancer-specific chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter, Genomics, vol.94, issue.6, pp.397-406, 2009.
DOI : 10.1016/j.ygeno.2009.08.013

H. Khan, Molecular evolution and tempo of amplification of human LINE-1, 2010.

A. Macia, Epigenetic Control of Retrotransposon Expression in Human Embryonic Stem Cells, Molecular and Cellular Biology, vol.31, issue.2, pp.300-316, 2011.
DOI : 10.1128/MCB.00561-10

K. Mätlik, L1 Antisense Promoter Drives Tissue-Specific Transcription of Human Genes, Journal of Biomedicine and Biotechnology, vol.3, issue.10, p.71753, 2006.
DOI : 10.1038/nrg908

P. Nigumann, Many Human Genes Are Transcribed from the Antisense Promoter of L1 Retrotransposon, Genomics, vol.79, issue.5, pp.628-634, 2002.
DOI : 10.1006/geno.2002.6758

C. Philippe, Activation of individual L1 retrotransposon instances is restricted to celltype dependent permissive loci, Elife, vol.5, 2016.
DOI : 10.7554/elife.13926
URL : https://cdn.elifesciences.org/articles/13926/elife-13926-v2.pdf

M. Speek, Antisense Promoter of Human L1 Retrotransposon Drives Transcription of Adjacent Cellular Genes, Molecular and Cellular Biology, vol.21, issue.6, pp.1973-1985, 2001.
DOI : 10.1128/MCB.21.6.1973-1985.2001

E. M. Wolff, Hypomethylation of a LINE-1 Promoter Activates an Alternate Transcript of the MET Oncogene in Bladders with Cancer, PLoS Genetics, vol.67, issue.4, p.1000917, 2010.
DOI : 10.1371/journal.pgen.1000917.s013